Literature DB >> 5549989

Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism.

J Hirsh, I G McDonald, G A Hale, E F O'Sullivan, V M Jelinek.   

Abstract

The extent of early resolution of major pulmonary embolism observed in 10 patients after 24 hours of treatment with heparin was compared with that seen in 17 patients after 24 hours of treatment with streptokinase. The patients in the streptokinase group also received a loading dose of heparin and were treated with heparin by continuous infusion when their thrombin time returned to normal levels. All had pulmonary hypertension. Pulmonary embolism was classified as acute in the 10 patients in the heparin group. Seven of these patients showed no angiographic change, two showed slight improvement and one showed angiographic deterioration. There was a moderate and statistically insignificant fall in mean pulmonary arterial pressure and total pulmonary resistance. Fourteen of the 17 patients who were studied before and after streptokinase were classified as acute and three as subacute progressive major pulmonary embolism. Eight showed marked angiographic improvement, four moderate and two slight angiographic improvement. There was a moderate and statistically significant fall in the mean pulmonary arterial pressure and pulmonary vascular resistance. In addition, all seven patients in whom no angiographic improvement occurred during heparin therapy showed moderate or marked angiographic improvement after a further 24 hours of treatment with streptokinase. The results strongly suggest that streptokinase therapy accelerates thrombolysis in patients with acute major pulmonary embolism.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5549989      PMCID: PMC1930899     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  13 in total

Review 1.  Fibrinolysis.

Authors:  S Sherry
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

2.  Urokinase therapy in pulmonary thromboembolism.

Authors:  E Genton; P S Wolf
Journal:  Am Heart J       Date:  1968-11       Impact factor: 4.749

3.  Embolectomy for acute massive pulmonary embolism.

Authors:  D A Cooley; A C Beall
Journal:  Surg Gynecol Obstet       Date:  1968-04

4.  Heparin in the treatment of venous thrombo-embolic disease: administration, control and results.

Authors:  E F O'Sullivan; J Hirsh; R A McCarthy; G C de Gruchy
Journal:  Med J Aust       Date:  1968-07-27       Impact factor: 7.738

5.  Observations on the fate of large pulmonary emboli.

Authors:  A Chait; D Summers; N Krasnow; B M Wechsler
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1967-06

6.  Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent.

Authors:  A A Sasahara; J E Cannilla; J S Belko; R L Morse; A J Criss
Journal:  N Engl J Med       Date:  1967-11-30       Impact factor: 91.245

7.  Urokinase in pulnonary embolism.

Authors:  D E Tow; H N Wagner; R A Holmes
Journal:  N Engl J Med       Date:  1967-11-30       Impact factor: 91.245

8.  Pulmonary angiography in experimental pulmonary embolism.

Authors:  J E Dalen; V S Mathur; H Evans; F W Haynes; A A Pur-Shahriari; P D Stein; L Dexter
Journal:  Am Heart J       Date:  1966-10       Impact factor: 4.749

9.  Streptokinase therapy in acute major pulmonary embolism: effectiveness and problems.

Authors:  J Hirsh; G S Hale; I G McDonald; R A McCarthy; A Pitt
Journal:  Br Med J       Date:  1968-12-21

10.  Treatment of pulmonary embolism with streptokinase. A preliminary report.

Authors:  G A Miller; R V Gibson; M Honey; G C Sutton
Journal:  Br Med J       Date:  1969-03-29
View more
  11 in total

Review 1.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

2.  [Medical treatment of venous thromboembolism (author's transl)].

Authors:  J C van de Loo
Journal:  Langenbecks Arch Chir       Date:  1977-11

Review 3.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  The rate of resolution of clot burden measured by pulmonary CT angiography in patients with acute pulmonary embolism.

Authors:  Ayaz Aghayev; Alessandro Furlan; Amol Patil; Serter Gumus; Kyung Nyeo Jeon; Bumwoo Park; Kyongtae T Bae
Journal:  AJR Am J Roentgenol       Date:  2013-04       Impact factor: 3.959

Review 5.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Anaesthetic technique for transvenous pulmonary embolectomy.

Authors:  M E Goldberg; J H Moore; B E Jarrell; J L Seltzer
Journal:  Can Anaesth Soc J       Date:  1986-01

7.  Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism.

Authors:  D A Tibbutt; J A Davies; J A Anderson; E W Fletcher; J Hamill; J M Holt; M L Thomas; G Lee; G A Miller; A A Sharp; G C Sutton
Journal:  Br Med J       Date:  1974-03-02

8.  Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.

Authors:  J Hirsh; J F Cade; E Regoeczi; M Gent; M R Buchanan; D M Hynes
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

Review 9.  Pulmonary embolism--the role of thrombolytic therapy in its management.

Authors:  R S More; A Chauhan
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

10.  Thrombolytic therapy for pulmonary embolism.

Authors:  Zhiliang Zuo; Jirong Yue; Bi Rong Dong; Taixiang Wu; Guan J Liu; Qiukui Hao
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.